Bridgeway Capital Management’s Amneal Pharmaceuticals AMRX Stock Holding History

Bridgeway Capital Management’s Portfolio AMRX Stock Details AMRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.84M	Hold	106,449	–	–	0.03%	589
2026 Q1	$1.32M	Sell	106,449 -5,000	-4%	-$67.1K	0.03%	642
2025 Q4	$1.4M	Buy	+111,449	New	+$1.28M	0.03%	633
2021 Q4	–	Sell	-83,200	Closed	-$444K	–	1261
2021 Q3	$444K	Hold	83,200	–	–	0.01%	1070
2021 Q2	$426K	Sell	83,200 -12,400	-13%	-$70.5K	0.01%	1115
2021 Q1	$643K	Sell	95,600 -186,800	-66%	-$1.04M	0.01%	1025
2020 Q4	$1.29M	Buy	282,400 +18,400	+7%	+$81.5K	0.03%	684
2020 Q3	$1.02M	Buy	264,000 +18,500	+8%	+$79.1K	0.02%	673
2020 Q2	$1.17M	Buy	+245,500	New	+$1.01M	0.02%	607

Other funds holding AMRX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

TGA

TPG GP A Fort Worth, Texas $5B AUM 58.56% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

RCMNY

Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

Bridgeway Capital Management's AMRX Position: Q2 2026 in Review

Bridgeway Capital Management held its Amneal Pharmaceuticals (AMRX) position steady in Q2 2026 at 106,449 shares worth $1.84M. The position accounts for 0.03% of the portfolio, ranked #589.

Bridgeway Capital Management first reported a position in AMRX in Q2 2020 and has held it in 9 quarters since. 311 funds tracked by Wall St. Rank hold AMRX as of Q2 2026.

Bridgeway Capital Management held 106,449 shares of Amneal Pharmaceuticals worth $1.84M as of Q2 2026.
Bridgeway Capital Management left its Amneal Pharmaceuticals share count unchanged in Q2 2026.
Amneal Pharmaceuticals made up 0.03% of Bridgeway Capital Management's portfolio in Q2 2026, its #589 holding.
Bridgeway Capital Management first reported a position in Amneal Pharmaceuticals in Q2 2020 and has held it in 9 quarters since.
311 funds tracked by Wall St. Rank held Amneal Pharmaceuticals as of Q2 2026.

Based on Bridgeway Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.